Project Grant K01DA062014
Award Date
12/15/24
Completion Date
11/30/29
Dollars Obligated
$181K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
This $180,606 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will enable the Icahn School of Medicine at Mount Sinai (ISMMS) to investigate cocaine-induced, cell-type and circuit-specific proteomic changes in the nucleus accumbens. The goal is to elucidate the interplay between drug-induced synaptic proteomic adaptations and the underlying transcriptional responses within the brain's reward regions. The...
This $492,000 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports cutting-edge research to elucidate the genetic and epigenetic factors governing cocaine addiction. The University of Chicago, the prime awardee, will employ a multidimensional approach involving genomics, epigenomics, neuroscience, and computational biology. The key objectives include: 1) Profiling cell-type and circuit-specific...
This federal Project Grant award of $892,816 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to elucidate the cellular and behavioral functions of astrocytic dopamine signaling in the nucleus accumbens (NAc) region of the brain. The research project, led by the University of Pittsburgh, seeks to characterize the role of NAc astrocytic dopamine D1 receptors and their downstream signaling in the induction and expression of...
The National Institute on Drug Abuse (NIDA) awarded Vanderbilt University a $149,284 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 26, 2024. The grant aims to define how chronic cocaine use disrupts the brain's dopaminergic system and its ability to process aversive stimuli. Specifically, the project will use single-cell calcium imaging and optogenetic manipulation in behaving animals to establish the temporal conditions under which dopamine...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the role of astrocyte mitochondrial bioenergetics in opiate-induced plasticity and relapse. The $201,250 award to The Research Foundation for the State University of New York (RF SUNY) will fund research to: 1) Identify the role of astrocyte mitochondrial oxidative phosphorylation in mediating heroin-induced plasticity, and 2)...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $158,024 to the University of California, Irvine to investigate the role of the gene GILZ in regulating cocaine-induced cellular activity and cocaine-associated memory formation. The research aims to determine if GILZ, an X-linked gene, mediates sex-dependent transcriptional changes underlying reward-associated behaviors in response to...
This $505,993 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs supports research at the University of California, San Diego (UCSD) to investigate the differential roles of prefrontal cortical interneurons in drug-seeking behavior after withdrawal from cocaine use.
The key objectives are to: 1) directly monitor the activity of different types of interneurons in the infralimbic cortex during cocaine...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $249,236 to Duke University to investigate the role of chromatin regulation and the expression of the brain-derived neurotrophic factor (BDNF) gene in driving persistent drug-seeking behaviors associated with cocaine addiction.
The project will use innovative molecular genetic techniques to define changes in the chromatin architecture...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $295,325 to support the development of a novel epigenetic regulator as a treatment for cocaine use disorder. The project, conducted by Epivario Inc., a for-profit biotechnology company, aims to establish a new lead compound, EPV, as a viable ACSS2 inhibitor with improved pharmacological properties compared to the previously tested ADG-205...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $136,929 Project Grant to Vanderbilt University to research the circuit mechanisms underlying inflexible habitual behaviors following chronic cocaine use. The objectives are to 1) determine if a history of cocaine self-administration alters dopamine release to promote habitual behaviors, 2) assess how cocaine self-administration changes neural activity patterns associated...